We report a 44-year-old Western Australian man who suffered a cardiac arrest several hours after a bite by a brown snake. He was successfully resuscitated after bolus administration of undiluted brown snake antivenom. We suggest that an initial bolus dose of at least five ampoules (5000 units) of undiluted brown snake antivenom should be given as primary therapy for cardiac arrest following brown snake envenomation in Western Australia. (MJA 2002; 177: 646-649)
Brown snakes are the leading cause of both snakebites and snakebite fatalities in Australia.1,2 The characteristic feature of significant envenomation by brown snakes is defibrination coagulopathy caused by potent procoagulants in the venom. However, the cause of cardiac arrest after this envenomation is unclear.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Swan District Hospital, Middle Swan, WA.
- 2 Royal Perth Hospital, Perth, WA.
- 1. Sutherland SK. Deaths from snake bite in Australia, 1981–1991. Med J Aust 1992; 157: 740-746.
- 2. Sutherland SK, Leonard RL. Snakebite deaths in Australia 1992–1994 and a management update. Med J Aust 1995; 163: 616-618.
- 3. Tibballs J, Sutherland S, Kerr S. Studies on Australian snake venoms. Part 1: The haemodynamic effects of brown snake (Pseudonaja) species in the dog. Anaesth Intensive Care 1989; 17: 466-469.
- 4. Tibballs J, Sutherland SK. The efficacy of heparin in the treatment of common brown snake (Pseudonaja textilis) envenomation. Anaesth Intensive Care 1992; 20: 33-37.
- 5. Henderson A, Baldwin LN, May C. Fatal brown snake (Pseudonaja textilis) envenomation despite the use of antivenom. Med J Aust 1993; 158: 709-710.
- 6. Sprivulis P, Jelinek GA. Fatal intracranial haematomas in two patients with brown snake envenomation. Med J Aust 1995; 162: 215-216.
- 7. Grubb NR, Fox KAA, Cawood P. Resuscitation from out-of-hospital cardiac arrest: implications for cardiac enzyme estimation. Resuscitation 1996; 33: 35-41.
- 8. Marshall LR, Herrman RP. Coagulant and anticoagulant actions of Australian snake venoms. Thromb Haemost 1983; 50: 707-711.
- 9. Sutherland SK, Coulter AR, Broad AJ, et al. Human snake bite victims: the successful detection of circulating snake venom by radioimmunoassay. Med J Aust 1975; 1: 27-29.
- 10. Sutherland SK. Australian animal toxins. Melbourne: Oxford University Press, 1983.
- 11. Tibballs J, Sutherland S. The efficacy of antivenom in prevention of cardiovascular depression and coagulopathy induced by brown snake (Pseudonaja) species. Anaesth Intensive Care 1991; 19: 530-534.
- 12. White J. Management of brown snake envenoming [editorial]. Crit Care Resuscitation 2002; 4: 84-86.
- 13. Sprivulis P, Jelinek GA, Marshall L. Efficacy and potency of antivenoms in neutralizing the procoagulant effects of Australian snake venoms in dog and human plasma. Anaesth Intensive Care 1996; 24: 379-381.
- 14. White J. CSL antivenom handbook. Melbourne: CSL 1995.
- 15. Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med 2002; 347: 347-356.
- 16. Sutherland SK, Tibballs J. Australian animal toxins: the creatures, their toxins and care of the poisoned patient. South Melbourne: Oxford University Press, 2001.
- 17. White J. Why do people still die from brown-snake bites? Emerg Med 2000; 12: 204-206.